Human Immunoglobulin G class drugs
5 results
Bivigam (immune globulin intravenous (human) 10%)
(Immune Globulin Intravenous (Human) 10%)ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency in adults and children aged 2 years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Cuvitru (immune globulin subcutaneous (human))
(Immune Globulin Subcutaneous (Human))Takeda Pharmaceuticals America, Inc.
Usage: CUVITRU is indicated for replacement therapy in primary humoral immunodeficiency in patients aged two years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Flebogamma (immune globulin (human))
(Immune Globulin (Human))GRIFOLS USA, LLC
Usage: Flebogamma 5% DIF is indicated for the treatment of primary immunodeficiency in adults and pediatric patients aged 2 years and older, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.
Gamastan (immune globulin (human))
(immune globulin (human))GRIFOLS USA, LLC
Usage: GAMASTAN is a human immune globulin indicated for prophylaxis against hepatitis A after exposure, prevention/modification of measles in susceptible individuals post-exposure, modification of varicella, and rubella in exposed women who won't consider abortion. It is not indicated for hepatitis B prophylaxis or routine vaccinations.
Octagam immune globulin (human) (immune globulin)
(Immune Globulin)Octapharma USA Inc
Usage: Octagam is indicated for the treatment of primary humoral immunodeficiency diseases (PI), including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. It is administered as a 5% intravenous immune globulin solution.